Skip to main content
Top
Published in: Substance Abuse Treatment, Prevention, and Policy 1/2009

Open Access 01-12-2009 | Debate

Problem drug use the public health imperative: what some of the literature says

Author: Gez Bevan

Published in: Substance Abuse Treatment, Prevention, and Policy | Issue 1/2009

Login to get access

Abstract

Background

With more than 200,000 problem drug users is contact with structured treatment services in England the public health imperative behind drug treatment is great. Problem drug use for many is a chronic and relapsing condition, where "cure" is often neither a reasonable or appropriate expectation and it can further be argued that in these circumstances problem drug use is no different from any number of chronic and enduring health conditions that are managed in the health care system and therefore should be conceptualised as such.

Discussion

A public health approach to drug treatment emphasises the need for drug users in or accessing treatment, to reduce their harmful drug use, reduce drug use related risks such as sepsis and overdose and stay alive for longer. However a public health perspective in relation to problem drug use isn't always either apparent or readily understood and to that end there is still a significant need to continue the arguments and debate that treatment and interventions for problem and dependent drug users need to extend beyond an individualistic approach. For the purposes of discussion in this article public and population health will be used interchangeably.

Summary

A recognition and acceptance that a public and population health approach to the management of problem drug users is sound public health policy also then requires a long term commitment in terms of staffing and resources where service delivery mirrors that of chronic condition management.
Literature
1.
go back to reference National Treatment Agency for Substance Misuse Numbers in Treatment, Drug Treatment Activity 2007/8. NTA. National Treatment Agency for Substance Misuse Numbers in Treatment, Drug Treatment Activity 2007/8. NTA.
2.
go back to reference Newcombe R: The reduction of drug related harm: a conceptual framework for theory, practice and research. The reduction of drug related harm. Edited by: O'Hare PA, Newcombe R, Matthews A, Buning EC, Drucker E. 1992, London Routledge Newcombe R: The reduction of drug related harm: a conceptual framework for theory, practice and research. The reduction of drug related harm. Edited by: O'Hare PA, Newcombe R, Matthews A, Buning EC, Drucker E. 1992, London Routledge
3.
go back to reference Ritter , Cameron : A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit. Drug & Alcohol Review. 2006, 25 (6): 611-24. 10.1080/09595230600944529.CrossRef Ritter , Cameron : A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit. Drug & Alcohol Review. 2006, 25 (6): 611-24. 10.1080/09595230600944529.CrossRef
5.
go back to reference Stimson G: Aids and injecting drug users in the UK 1987-1993, the policy response to an epidemic. Social Science and Medicine. 1995, 41 (5): 699-716. 10.1016/0277-9536(94)00435-V.PubMedCrossRef Stimson G: Aids and injecting drug users in the UK 1987-1993, the policy response to an epidemic. Social Science and Medicine. 1995, 41 (5): 699-716. 10.1016/0277-9536(94)00435-V.PubMedCrossRef
6.
go back to reference Judd A, Hickman M, McDonald T, Parry J, Stimson V, Hall A: Incidence of Hepatitis C virus and HIV among new injecting drug users in London: A prospective cohort study. British Medical Journal. 2005, 330 (7481): 24-25. 10.1136/bmj.38286.841227.7C.PubMedCentralPubMedCrossRef Judd A, Hickman M, McDonald T, Parry J, Stimson V, Hall A: Incidence of Hepatitis C virus and HIV among new injecting drug users in London: A prospective cohort study. British Medical Journal. 2005, 330 (7481): 24-25. 10.1136/bmj.38286.841227.7C.PubMedCentralPubMedCrossRef
7.
go back to reference Brown T, King A: Understanding the psychological effects of street drugs. 2007, Mind Publications Brown T, King A: Understanding the psychological effects of street drugs. 2007, Mind Publications
8.
go back to reference National Treatment Agency for Substance Misuse: Models of Care for the treatment of drug misusers: Promoting quality, efficiency and effectiveness in drug misuse treatment services in England. 2002, National Treatment Agency National Treatment Agency for Substance Misuse: Models of Care for the treatment of drug misusers: Promoting quality, efficiency and effectiveness in drug misuse treatment services in England. 2002, National Treatment Agency
10.
go back to reference Scott CK, Foss MA, Dennis ML: Pathways in the relapse-treatment-recovery cycle over 3 years. Journal of Substance Abuse Treatments. 2005, 28 (suppl 1): 63-72. 10.1016/j.jsat.2004.09.006.CrossRef Scott CK, Foss MA, Dennis ML: Pathways in the relapse-treatment-recovery cycle over 3 years. Journal of Substance Abuse Treatments. 2005, 28 (suppl 1): 63-72. 10.1016/j.jsat.2004.09.006.CrossRef
11.
go back to reference Royal Pharmaceutical Society of Great Britain: Pharmacists and Methadone. Pharmacy Briefing. 2005 Royal Pharmaceutical Society of Great Britain: Pharmacists and Methadone. Pharmacy Briefing. 2005
12.
go back to reference McIntosh J, McKeganey N: Addicts' narratives of recovery from drug use: constructing a non-addict identity. Social Science and Medicine. 2000, 50 (10): 1501-10. 10.1016/S0277-9536(99)00409-8.PubMedCrossRef McIntosh J, McKeganey N: Addicts' narratives of recovery from drug use: constructing a non-addict identity. Social Science and Medicine. 2000, 50 (10): 1501-10. 10.1016/S0277-9536(99)00409-8.PubMedCrossRef
13.
go back to reference Leukefeld CG, Tims FM: Relapse and Recovery in drug abuse: research and practice. International Journal of Addiction. 1989, 4 (3): 189-201. Leukefeld CG, Tims FM: Relapse and Recovery in drug abuse: research and practice. International Journal of Addiction. 1989, 4 (3): 189-201.
14.
go back to reference Levy MS: Listening to our clients: The prevention of relapse. Journal of Psychoactive Drugs. 2008, 40 (2): 167-172.PubMedCrossRef Levy MS: Listening to our clients: The prevention of relapse. Journal of Psychoactive Drugs. 2008, 40 (2): 167-172.PubMedCrossRef
15.
go back to reference Scott CK, Dennis ML, Foss MA: Utilizing Recovery Management Checkups to shorten the cycle of relapse, treatment re-entry and recovery. Drug and Alcohol Dependency. 2005, 78 (3): 325-38. 10.1016/j.drugalcdep.2004.12.005.CrossRef Scott CK, Dennis ML, Foss MA: Utilizing Recovery Management Checkups to shorten the cycle of relapse, treatment re-entry and recovery. Drug and Alcohol Dependency. 2005, 78 (3): 325-38. 10.1016/j.drugalcdep.2004.12.005.CrossRef
16.
go back to reference Termorshuzen F, Krol A, Prions M, Van Ameijden: Long term outcomes of chronic drug use; the Amsterdam cohort among drug users. American journal of Epidemiology. 2005, 161 (3): 271-9. 10.1093/aje/kwi035.CrossRef Termorshuzen F, Krol A, Prions M, Van Ameijden: Long term outcomes of chronic drug use; the Amsterdam cohort among drug users. American journal of Epidemiology. 2005, 161 (3): 271-9. 10.1093/aje/kwi035.CrossRef
17.
go back to reference Royal College of General Practitioners: Handbook for Primary Care organisations and other providers of face to face training. 2004, RCGP Royal College of General Practitioners: Handbook for Primary Care organisations and other providers of face to face training. 2004, RCGP
18.
go back to reference McEvoy P, Barnes P: Using the chronic care model to tackle depression among older adults who have long-term physical conditions. Journal of Psychiatric & Mental health Nursing. 2007, 14 (3): 233-8. 10.1111/j.1365-2850.2007.01066.x.CrossRef McEvoy P, Barnes P: Using the chronic care model to tackle depression among older adults who have long-term physical conditions. Journal of Psychiatric & Mental health Nursing. 2007, 14 (3): 233-8. 10.1111/j.1365-2850.2007.01066.x.CrossRef
19.
go back to reference Hung D, Rundall T, Tallia A, Cohen D, Crabtree B: Rethinking prevention in Primary Care: applying the Chronic Care Model to address health risk behaviours. The Millbank Quarterly. 2007, 85 (1): 91-10.1111/j.1468-0009.2007.00477.x.CrossRef Hung D, Rundall T, Tallia A, Cohen D, Crabtree B: Rethinking prevention in Primary Care: applying the Chronic Care Model to address health risk behaviours. The Millbank Quarterly. 2007, 85 (1): 91-10.1111/j.1468-0009.2007.00477.x.CrossRef
20.
go back to reference Kugler C, Vlaminck H, Haverich A, Maes B: Non adherence with diet and fluid restrictions among adults having haemodialysis. Journal of Nursing Scholarship. 2005, 37 (1): 25-9. 10.1111/j.1547-5069.2005.00009.x.PubMedCrossRef Kugler C, Vlaminck H, Haverich A, Maes B: Non adherence with diet and fluid restrictions among adults having haemodialysis. Journal of Nursing Scholarship. 2005, 37 (1): 25-9. 10.1111/j.1547-5069.2005.00009.x.PubMedCrossRef
21.
go back to reference Maclean D, Lo R: the non-insulin dependent diabetic: success and failure of compliance Australian. Journal of Advanced Nursing. 1998, 15 (4): 32-42. Maclean D, Lo R: the non-insulin dependent diabetic: success and failure of compliance Australian. Journal of Advanced Nursing. 1998, 15 (4): 32-42.
22.
go back to reference Cramer JA: A systematic review of adherence with medication for diabetes. Diabetes Care. 2004, 27 (5): 1218-1224. 10.2337/diacare.27.9.2285.PubMedCrossRef Cramer JA: A systematic review of adherence with medication for diabetes. Diabetes Care. 2004, 27 (5): 1218-1224. 10.2337/diacare.27.9.2285.PubMedCrossRef
23.
go back to reference Swaby P, Wilson E, Swaby S, Sue-Ho R, Pierre R: Chronic diseases management in the Jamaican setting: HOPE worldwide Jamaica's experience. Papua and New Guinea Medicine. 2001, 44 (3-4): 171-5. Swaby P, Wilson E, Swaby S, Sue-Ho R, Pierre R: Chronic diseases management in the Jamaican setting: HOPE worldwide Jamaica's experience. Papua and New Guinea Medicine. 2001, 44 (3-4): 171-5.
24.
go back to reference Bhattacharaya N, Biswas R, Das MK, Chatterjee PS: A study of the compliance of diabetes mellitus patients. Indian Journal of Public Health. 2005, 49 (1): 34-5. Bhattacharaya N, Biswas R, Das MK, Chatterjee PS: A study of the compliance of diabetes mellitus patients. Indian Journal of Public Health. 2005, 49 (1): 34-5.
25.
go back to reference Bentley B, De Jong MJ, Moser DK, Peden : Factors related to non-adherence to a low salt diet recommendations in heart failure patients. European Journal of Cardio-Vascular. 2005, 4 (4): 331-6.CrossRef Bentley B, De Jong MJ, Moser DK, Peden : Factors related to non-adherence to a low salt diet recommendations in heart failure patients. European Journal of Cardio-Vascular. 2005, 4 (4): 331-6.CrossRef
26.
go back to reference Durose C, Holdworth M, Watson V, Prygrodzka : Knowledge of dietary restrictions and the medical consequences of non-compliance by patients on haemodialysis are not predictive of dietary compliance. Journal of the American Dietetics Association. 2004, 104 (1): 41-42. 10.1016/j.jada.2003.10.016.CrossRef Durose C, Holdworth M, Watson V, Prygrodzka : Knowledge of dietary restrictions and the medical consequences of non-compliance by patients on haemodialysis are not predictive of dietary compliance. Journal of the American Dietetics Association. 2004, 104 (1): 41-42. 10.1016/j.jada.2003.10.016.CrossRef
27.
go back to reference Zgibor JC, Simmons D: Barriers to blood glucose monitoring in a multiethnic community. Diabetes Care. 2002, 25 (10): 1772-7. 10.2337/diacare.25.10.1772.PubMedCrossRef Zgibor JC, Simmons D: Barriers to blood glucose monitoring in a multiethnic community. Diabetes Care. 2002, 25 (10): 1772-7. 10.2337/diacare.25.10.1772.PubMedCrossRef
28.
go back to reference Koch T, Jenkin P, Kralik D: Chronic Illness self management: locating the self. Journal of Advanced Nursing. 2004, 48 (5): 484-92. 10.1111/j.1365-2648.2004.03237.x.PubMedCrossRef Koch T, Jenkin P, Kralik D: Chronic Illness self management: locating the self. Journal of Advanced Nursing. 2004, 48 (5): 484-92. 10.1111/j.1365-2648.2004.03237.x.PubMedCrossRef
29.
go back to reference Karda P: Patient compliance with antibiotic treatments for respiratory tract infection. Journal of Antimicrobial Chemotherapy. 2002, 49 (6): 897-903. 10.1093/jac/dkf046.CrossRef Karda P: Patient compliance with antibiotic treatments for respiratory tract infection. Journal of Antimicrobial Chemotherapy. 2002, 49 (6): 897-903. 10.1093/jac/dkf046.CrossRef
30.
go back to reference Sanson-Fisher R, Bowman J, Armstrong S: Factors affecting the non-adherence with antibiotics. Diagnosing Microbiological Infectious Diseases. 1992, 15 (4 Suppl): 103-109. 10.1016/0732-8893(92)90136-H.CrossRef Sanson-Fisher R, Bowman J, Armstrong S: Factors affecting the non-adherence with antibiotics. Diagnosing Microbiological Infectious Diseases. 1992, 15 (4 Suppl): 103-109. 10.1016/0732-8893(92)90136-H.CrossRef
31.
go back to reference Kardas P: Comparison of patient compliance with once-daily and twice-daily antibiotic regimens in respiratory tract infections: results of a randomized trial. Journal of Antimicrobial Chemotherapy. 2007, 59 (3): 531-6. 10.1093/jac/dkl528.PubMedCrossRef Kardas P: Comparison of patient compliance with once-daily and twice-daily antibiotic regimens in respiratory tract infections: results of a randomized trial. Journal of Antimicrobial Chemotherapy. 2007, 59 (3): 531-6. 10.1093/jac/dkl528.PubMedCrossRef
32.
go back to reference Laudet AB, Becker JB, White WL: Don't wanna go through that madness no more: quality of life satisfaction as predictor of sustained remission from illicit drug misuse. Substance Use & Misuse. 2009, 44 (2): 227-52. 10.1080/10826080802714462.CrossRef Laudet AB, Becker JB, White WL: Don't wanna go through that madness no more: quality of life satisfaction as predictor of sustained remission from illicit drug misuse. Substance Use & Misuse. 2009, 44 (2): 227-52. 10.1080/10826080802714462.CrossRef
33.
go back to reference Appel PW, Ellison AA, Jansky HK, Oldak R: Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders. American Journal of Drug & Alcohol Abuse. 2004, 30 (1): 129-53. 10.1081/ADA-120029870.CrossRef Appel PW, Ellison AA, Jansky HK, Oldak R: Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders. American Journal of Drug & Alcohol Abuse. 2004, 30 (1): 129-53. 10.1081/ADA-120029870.CrossRef
34.
go back to reference Meier PS, Barrowclough C, Donmall MC: The role of the therapeutic alliance in the treatment of substance misuse: a critical review of the literature. Addiction. 2005, 100 (3): 304-16. 10.1111/j.1360-0443.2004.00935.x.PubMedCrossRef Meier PS, Barrowclough C, Donmall MC: The role of the therapeutic alliance in the treatment of substance misuse: a critical review of the literature. Addiction. 2005, 100 (3): 304-16. 10.1111/j.1360-0443.2004.00935.x.PubMedCrossRef
35.
go back to reference Sellman D: The 10 most important things known about addiction. Addiction. 2009, Sellman D: The 10 most important things known about addiction. Addiction. 2009,
36.
go back to reference Denning P: strategies for implementing harm reduction in treatment settings. Journal of Psychoactive Drugs. 2001, 33 (1): 23-6.PubMedCrossRef Denning P: strategies for implementing harm reduction in treatment settings. Journal of Psychoactive Drugs. 2001, 33 (1): 23-6.PubMedCrossRef
37.
go back to reference Keen J, Oliver P, Rowse G, Mathers N: Does Methadone Maintenance treatment based on the new national guidelines work in a primary care setting?. British Journal of General Practice. 2003, 461-466. Keen J, Oliver P, Rowse G, Mathers N: Does Methadone Maintenance treatment based on the new national guidelines work in a primary care setting?. British Journal of General Practice. 2003, 461-466.
38.
go back to reference Zhang Z, Friedmann PD, Gerstein DR: Does Retention Matter? Treatment duration and improvement in drug use. Addiction. 2003, 98 (5): 673-84. 10.1046/j.1360-0443.2003.00354.x.PubMedCrossRef Zhang Z, Friedmann PD, Gerstein DR: Does Retention Matter? Treatment duration and improvement in drug use. Addiction. 2003, 98 (5): 673-84. 10.1046/j.1360-0443.2003.00354.x.PubMedCrossRef
39.
go back to reference Stewart D, Gossop M, Marsden J: Reductions in non fatal overdose after drug treatment; results from the National Treatment Outcome Research Study (NTORS). Journal of Substance Abuse Treatments. 2002, 22 (1): 1-9. 10.1016/S0740-5472(01)00206-9.CrossRef Stewart D, Gossop M, Marsden J: Reductions in non fatal overdose after drug treatment; results from the National Treatment Outcome Research Study (NTORS). Journal of Substance Abuse Treatments. 2002, 22 (1): 1-9. 10.1016/S0740-5472(01)00206-9.CrossRef
40.
go back to reference Gossop M, Marsden J, Stewart D, Treacy S: Changes and stability after treatment of drug misuse: 2 year outcomes from the National Treatment outcome Research Study (UK). Addictive Behaviour. 2002, 27 (2): 155-66. 10.1016/S0306-4603(00)00174-X.CrossRef Gossop M, Marsden J, Stewart D, Treacy S: Changes and stability after treatment of drug misuse: 2 year outcomes from the National Treatment outcome Research Study (UK). Addictive Behaviour. 2002, 27 (2): 155-66. 10.1016/S0306-4603(00)00174-X.CrossRef
41.
go back to reference Gossop M, Marsden J, Stewart D, Kidd T: The National Treatment Outcome Research Study (NTORS) 4-5 year follow up result. Addiction. 2003, 98 (3): 291-303. 10.1046/j.1360-0443.2003.00296.x.PubMedCrossRef Gossop M, Marsden J, Stewart D, Kidd T: The National Treatment Outcome Research Study (NTORS) 4-5 year follow up result. Addiction. 2003, 98 (3): 291-303. 10.1046/j.1360-0443.2003.00296.x.PubMedCrossRef
42.
go back to reference Torrens M, Castillo C, Perez-Sola V: Retention in Methadone Maintenance programme. Drug and Alcohol Dependency. 1996, 41 (1): 55-9. 10.1016/0376-8716(96)01230-6.CrossRef Torrens M, Castillo C, Perez-Sola V: Retention in Methadone Maintenance programme. Drug and Alcohol Dependency. 1996, 41 (1): 55-9. 10.1016/0376-8716(96)01230-6.CrossRef
43.
go back to reference D'Ippoliti D, Davoli M, Perucci CA, Pasqualini F, Bergagli AM: Retention in treatment of heroin users in Italy; the role of treatment type and of methadone maintenance dosage. Drug and Alcohol Dependency. 1998, 167-71. 10.1016/S0376-8716(98)00091-X. 2 D'Ippoliti D, Davoli M, Perucci CA, Pasqualini F, Bergagli AM: Retention in treatment of heroin users in Italy; the role of treatment type and of methadone maintenance dosage. Drug and Alcohol Dependency. 1998, 167-71. 10.1016/S0376-8716(98)00091-X. 2
45.
go back to reference Gerra G, Ferru M, Polidori E, Santoro G, Zaimovic A, Sterniere E: Long term methadone maintenance effectiveness: psychosocial and pharmacological variables. Journal of Substance Misuse Abuse treatment. 2003, 25 (1): 1-8. 10.1016/S0740-5472(03)00031-X.CrossRef Gerra G, Ferru M, Polidori E, Santoro G, Zaimovic A, Sterniere E: Long term methadone maintenance effectiveness: psychosocial and pharmacological variables. Journal of Substance Misuse Abuse treatment. 2003, 25 (1): 1-8. 10.1016/S0740-5472(03)00031-X.CrossRef
46.
go back to reference Brady TM, Salvucci S, Sverdlov LS, Male A, Kyeyune H, Sikali E, Desale S, Yu P: Methadone dosage and retention: an examination of the 60 mh/day threshold. Journal of Addictive Diseases. 2005, 24 (3): 23-47. 10.1300/J069v24n03_03.PubMedCrossRef Brady TM, Salvucci S, Sverdlov LS, Male A, Kyeyune H, Sikali E, Desale S, Yu P: Methadone dosage and retention: an examination of the 60 mh/day threshold. Journal of Addictive Diseases. 2005, 24 (3): 23-47. 10.1300/J069v24n03_03.PubMedCrossRef
47.
go back to reference VIllafranca SW, McKellar JD, Trafton JA, Humphreys K: Predictors of retention in methadone programmes: A signal detection analysis. Drug & Alcohol Dependence. 2006, 83 (3): 218-24. 10.1016/j.drugalcdep.2005.11.020.CrossRef VIllafranca SW, McKellar JD, Trafton JA, Humphreys K: Predictors of retention in methadone programmes: A signal detection analysis. Drug & Alcohol Dependence. 2006, 83 (3): 218-24. 10.1016/j.drugalcdep.2005.11.020.CrossRef
48.
go back to reference Joe GW, Simpson DD, Hubbard RL: treatment predictors of tenure in methadone maintenance. Journal of Substance Abuse. 1991, 3 (1): 73-84. 10.1016/S0899-3289(05)80007-0.PubMedCrossRef Joe GW, Simpson DD, Hubbard RL: treatment predictors of tenure in methadone maintenance. Journal of Substance Abuse. 1991, 3 (1): 73-84. 10.1016/S0899-3289(05)80007-0.PubMedCrossRef
49.
go back to reference Hartel DM, Schoenbaum EE, Selwyn PA, Kline J, Davenny K, Klein RS, Friedland GH: Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. American Journal of Public Health. 1995, 85 (1): 83-88. 10.2105/AJPH.85.1.83.PubMedCentralPubMedCrossRef Hartel DM, Schoenbaum EE, Selwyn PA, Kline J, Davenny K, Klein RS, Friedland GH: Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. American Journal of Public Health. 1995, 85 (1): 83-88. 10.2105/AJPH.85.1.83.PubMedCentralPubMedCrossRef
50.
go back to reference Bell J, Chan J, Kuk A: Investigating the influence of treatment philosophy on outcomes of methadone maintenance. Addiction. 1995, 90 (6): 823-30. 10.1111/j.1360-0443.1995.tb02231.x.PubMedCrossRef Bell J, Chan J, Kuk A: Investigating the influence of treatment philosophy on outcomes of methadone maintenance. Addiction. 1995, 90 (6): 823-30. 10.1111/j.1360-0443.1995.tb02231.x.PubMedCrossRef
51.
go back to reference Strain EC, Bigelow GE, Liebson IA, Stitzer ML: Moderate v high does methadone in the treatment of opioid dependence: a randomized control trial. The Journal of the American Medical Association. 1999, 281 (11): 1000-5. 10.1001/jama.281.11.1000.PubMedCrossRef Strain EC, Bigelow GE, Liebson IA, Stitzer ML: Moderate v high does methadone in the treatment of opioid dependence: a randomized control trial. The Journal of the American Medical Association. 1999, 281 (11): 1000-5. 10.1001/jama.281.11.1000.PubMedCrossRef
52.
go back to reference Farre M, Mas A, Torrens M, Moreno V, Cami J: Retention and illicit opioid use during methadone maintenance interventions: a Meta analysis. Drug and Alcohol Dependence. 2002, 65 (3): 283-90. 10.1016/S0376-8716(01)00171-5.PubMedCrossRef Farre M, Mas A, Torrens M, Moreno V, Cami J: Retention and illicit opioid use during methadone maintenance interventions: a Meta analysis. Drug and Alcohol Dependence. 2002, 65 (3): 283-90. 10.1016/S0376-8716(01)00171-5.PubMedCrossRef
53.
go back to reference Epstein DH, Schmittner J, Umbricht A, Schroeder JR, Moolchan ET, Preston KL: Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. Drug Alcohol Dependence. 2009, 101 (1-2): 92-100. 10.1016/j.drugalcdep.2008.11.006.PubMedCentralPubMedCrossRef Epstein DH, Schmittner J, Umbricht A, Schroeder JR, Moolchan ET, Preston KL: Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. Drug Alcohol Dependence. 2009, 101 (1-2): 92-100. 10.1016/j.drugalcdep.2008.11.006.PubMedCentralPubMedCrossRef
54.
go back to reference Langendam MW, Van Brussel GH, Coutinho RA, Van Ameijden EJ: Methadone Maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study. Addiction. 2000, 95 (4): 591-600. 10.1046/j.1360-0443.2000.95459110.x.PubMedCrossRef Langendam MW, Van Brussel GH, Coutinho RA, Van Ameijden EJ: Methadone Maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study. Addiction. 2000, 95 (4): 591-600. 10.1046/j.1360-0443.2000.95459110.x.PubMedCrossRef
55.
go back to reference Langendam MW, Van Brussel GH, Coutinho RA, Van Ameijden EJ: The impact of harm reduction based methadone maintenance treatment on mortality among heroin users. American Journal of Public Health. 2001, 91 (5): 774-80. 10.2105/AJPH.91.5.774.PubMedCentralPubMedCrossRef Langendam MW, Van Brussel GH, Coutinho RA, Van Ameijden EJ: The impact of harm reduction based methadone maintenance treatment on mortality among heroin users. American Journal of Public Health. 2001, 91 (5): 774-80. 10.2105/AJPH.91.5.774.PubMedCentralPubMedCrossRef
56.
go back to reference Bao YP, Liu ZM, Epstein DH, Du C, Shi J, Lu L: A meta-analysis of retention in methadone maintenance by dose and dosing strategy. The American journal of drug and alcohol abuse. 2009, 35 (1): 28-33. 10.1080/00952990802342899.PubMedCentralPubMedCrossRef Bao YP, Liu ZM, Epstein DH, Du C, Shi J, Lu L: A meta-analysis of retention in methadone maintenance by dose and dosing strategy. The American journal of drug and alcohol abuse. 2009, 35 (1): 28-33. 10.1080/00952990802342899.PubMedCentralPubMedCrossRef
57.
go back to reference Hunter G, Stimson G, Judd A, Jones S, Hickman M: Measuring injecting risk behaviour in the 2nd decade of harm reduction: A survey of injecting drug users in England. Addiction. 2000, 95 (9): 1351-61. 10.1046/j.1360-0443.2000.95913516.x.PubMedCrossRef Hunter G, Stimson G, Judd A, Jones S, Hickman M: Measuring injecting risk behaviour in the 2nd decade of harm reduction: A survey of injecting drug users in England. Addiction. 2000, 95 (9): 1351-61. 10.1046/j.1360-0443.2000.95913516.x.PubMedCrossRef
58.
go back to reference Hope VD, Judd A, Hickman M, Sutton A, Stimson GV, Parry JV, Gill ON: HIV prevalence amongst injecting drug user in England and Wales1990-2003: evidence for increased transmission in recent years. AIDS. 2005, 19 (11): 1207-14. 10.1097/01.aids.0000176222.71355.a1.PubMedCrossRef Hope VD, Judd A, Hickman M, Sutton A, Stimson GV, Parry JV, Gill ON: HIV prevalence amongst injecting drug user in England and Wales1990-2003: evidence for increased transmission in recent years. AIDS. 2005, 19 (11): 1207-14. 10.1097/01.aids.0000176222.71355.a1.PubMedCrossRef
59.
go back to reference Bury K, Ross A, Van Teijlingen E, Porter A, Bath G: Lothian General Practitioners, HIV infection and drug misuse: epidemiology, experience and confidence 1988-1993. Health Bulletin (Edinb). 1996, 54 (3): 258-69. Bury K, Ross A, Van Teijlingen E, Porter A, Bath G: Lothian General Practitioners, HIV infection and drug misuse: epidemiology, experience and confidence 1988-1993. Health Bulletin (Edinb). 1996, 54 (3): 258-69.
60.
go back to reference Davies AG, Cormack RM, Richardson AM: Estimation of injecting drug users in the City of Edinburgh, Scotland and number infected with Immunodeficiency virus. International Journal of Epidemiology. 1999, 28 (1): 117-21. 10.1093/ije/28.1.117.PubMedCrossRef Davies AG, Cormack RM, Richardson AM: Estimation of injecting drug users in the City of Edinburgh, Scotland and number infected with Immunodeficiency virus. International Journal of Epidemiology. 1999, 28 (1): 117-21. 10.1093/ije/28.1.117.PubMedCrossRef
61.
go back to reference Seaman SR, Bird SM, Brettle RP: Historical HIV prevalence in Edinburgh prison: a database linkage study. Journal of Epidemiology and Biostatistics. 2000, 5 (4): 245-250.PubMed Seaman SR, Bird SM, Brettle RP: Historical HIV prevalence in Edinburgh prison: a database linkage study. Journal of Epidemiology and Biostatistics. 2000, 5 (4): 245-250.PubMed
62.
go back to reference Parsons J, Hickman M, Turnball PJ, McSweeny T, Stimson GV, Judd A, Roberts K: Over a decade of syringe exchange: results from 1997 UK survey. Addiction. 2002, 845-50. 10.1046/j.1360-0443.2002.00128.x. 7 Parsons J, Hickman M, Turnball PJ, McSweeny T, Stimson GV, Judd A, Roberts K: Over a decade of syringe exchange: results from 1997 UK survey. Addiction. 2002, 845-50. 10.1046/j.1360-0443.2002.00128.x. 7
63.
go back to reference Brettle RP, Bisset K, Burns S, Davidson J, Davidson SJ, Gray JM, Inglis JM, Lees JS, Mok J: Human immunodeficiency virus and drug misuse: the Edinburgh experience. British Medical Journal. 1987, 295 (6595): 421-4. 10.1136/bmj.295.6595.421.PubMedCentralPubMedCrossRef Brettle RP, Bisset K, Burns S, Davidson J, Davidson SJ, Gray JM, Inglis JM, Lees JS, Mok J: Human immunodeficiency virus and drug misuse: the Edinburgh experience. British Medical Journal. 1987, 295 (6595): 421-4. 10.1136/bmj.295.6595.421.PubMedCentralPubMedCrossRef
65.
go back to reference Stimson GV: "Harm reduction--coming of age": a local movement with global impact. International Journal of Drug Policy. 2007, 18 (2): 67-9. 10.1016/j.drugpo.2006.12.012.PubMedCrossRef Stimson GV: "Harm reduction--coming of age": a local movement with global impact. International Journal of Drug Policy. 2007, 18 (2): 67-9. 10.1016/j.drugpo.2006.12.012.PubMedCrossRef
66.
go back to reference Mohsen AH, Murad S, Easterbrook PJ: Prevalence of hepatitis C in an ethnically diverse HIV-1 infected cohort in South London. HIV Medicine. 2005, 206-15. 10.1111/j.1468-1293.2005.00291.x. 3 Mohsen AH, Murad S, Easterbrook PJ: Prevalence of hepatitis C in an ethnically diverse HIV-1 infected cohort in South London. HIV Medicine. 2005, 206-15. 10.1111/j.1468-1293.2005.00291.x. 3
67.
go back to reference Pybus OG, Cochrane A, Holmes EC, Simmonds P: The hepatitis C virus epidemic infection among injecting drug users. Infection Genetics and Evolution. 2005, 5 (2): 131-9. 10.1016/j.meegid.2004.08.001.CrossRef Pybus OG, Cochrane A, Holmes EC, Simmonds P: The hepatitis C virus epidemic infection among injecting drug users. Infection Genetics and Evolution. 2005, 5 (2): 131-9. 10.1016/j.meegid.2004.08.001.CrossRef
68.
go back to reference Smyth BP, Keenan E, O'Connor JJ: Blood borne viral infection in Irish injecting drug users. Addiction. 1998, 93 (11): 1649-56. 10.1046/j.1360-0443.1998.931116493.x.PubMedCrossRef Smyth BP, Keenan E, O'Connor JJ: Blood borne viral infection in Irish injecting drug users. Addiction. 1998, 93 (11): 1649-56. 10.1046/j.1360-0443.1998.931116493.x.PubMedCrossRef
69.
go back to reference Das HK, Borkakoty BJ, Mahanta J, Medhi GK, Chelleng PK: Hepatitis C virus infection and risk behaviors among injection drug users of Nagaland. Indian Journal of Gastroenterology. 2007, 26 (5): 253-PubMed Das HK, Borkakoty BJ, Mahanta J, Medhi GK, Chelleng PK: Hepatitis C virus infection and risk behaviors among injection drug users of Nagaland. Indian Journal of Gastroenterology. 2007, 26 (5): 253-PubMed
70.
go back to reference Chelleng PK, Borkakoty BJ, Chetia M, Das HK, Mahanta J: Risk of hepatitis C infection among injection drug users in Mizoram, India. The Indian Journal of Medical Research. 2008, 128 (5): 640-6.PubMed Chelleng PK, Borkakoty BJ, Chetia M, Das HK, Mahanta J: Risk of hepatitis C infection among injection drug users in Mizoram, India. The Indian Journal of Medical Research. 2008, 128 (5): 640-6.PubMed
71.
go back to reference Shrestha SM, Shrestha DM, Gafney TE, Maharajan KG, Tsuda F, Okamoto H: Hepatitis B & C infection among drug users in Nepal. Tropical Gastroenterology. 1996, 17 (4): 212-3.PubMed Shrestha SM, Shrestha DM, Gafney TE, Maharajan KG, Tsuda F, Okamoto H: Hepatitis B & C infection among drug users in Nepal. Tropical Gastroenterology. 1996, 17 (4): 212-3.PubMed
72.
go back to reference Patrick DM, Buxton JA, Bingham M, Mathias RG: Public Health and Hepatitis C. Canadian Journal of Public Health. 2000, 91 (Suppl 1): s18-21.PubMed Patrick DM, Buxton JA, Bingham M, Mathias RG: Public Health and Hepatitis C. Canadian Journal of Public Health. 2000, 91 (Suppl 1): s18-21.PubMed
73.
go back to reference Miller Cl, Johnston C, Spittal PM, Li K, Laliberte N, Montaner JS, Schechter MT: Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002, 36 (3): 737-42. 10.1053/jhep.2002.35065.PubMedCrossRef Miller Cl, Johnston C, Spittal PM, Li K, Laliberte N, Montaner JS, Schechter MT: Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002, 36 (3): 737-42. 10.1053/jhep.2002.35065.PubMedCrossRef
74.
go back to reference Dawson AJ: An ethical argument in favour of routine hepatitis B vaccination in very low-incidence countries. The Lancet Infectious Diseases. 2005, 5 (2): 120-5.PubMedCrossRef Dawson AJ: An ethical argument in favour of routine hepatitis B vaccination in very low-incidence countries. The Lancet Infectious Diseases. 2005, 5 (2): 120-5.PubMedCrossRef
75.
go back to reference Perrett K, Granerød J, Crowcroft N, Carlisle R: Changing epidemiology of hepatitis A: should we be doing more to vaccinate injecting drug. Communicable Disease & Public Health. 2003, 6 (2): 97-100. Perrett K, Granerød J, Crowcroft N, Carlisle R: Changing epidemiology of hepatitis A: should we be doing more to vaccinate injecting drug. Communicable Disease & Public Health. 2003, 6 (2): 97-100.
76.
go back to reference Bradshaw CS, Pierce LI, Tabrizi SN, Fairley CK, Garland SM: Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sample. Sexually Transmitted Infections. 2005, 81 (1): 53-58. 10.1136/sti.2004.009423.PubMedCentralPubMedCrossRef Bradshaw CS, Pierce LI, Tabrizi SN, Fairley CK, Garland SM: Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sample. Sexually Transmitted Infections. 2005, 81 (1): 53-58. 10.1136/sti.2004.009423.PubMedCentralPubMedCrossRef
77.
go back to reference McGregor J, Marks PJ, Hayward A, Bell Y, Slack RC: Factors influencing hepatitis B vaccine uptake in injecting drug users. Journal of Public Health. 2003, 25 (2): 165-70. 10.1093/pubmed/fdg035.CrossRef McGregor J, Marks PJ, Hayward A, Bell Y, Slack RC: Factors influencing hepatitis B vaccine uptake in injecting drug users. Journal of Public Health. 2003, 25 (2): 165-70. 10.1093/pubmed/fdg035.CrossRef
78.
go back to reference Hunt DR, Saab S: Viral hepatitis in incarcerated adults: a medical and public health concern. The American Journal of Gastroenterology. 2009, 104 (4): 1024-31. 10.1038/ajg.2008.143.PubMedCrossRef Hunt DR, Saab S: Viral hepatitis in incarcerated adults: a medical and public health concern. The American Journal of Gastroenterology. 2009, 104 (4): 1024-31. 10.1038/ajg.2008.143.PubMedCrossRef
79.
go back to reference Sherriff LC, Mayon-White RT: A survey of hepatitis C prevalence amongst the homeless community in Oxford. Journal of Public Health Medicine. 2003, 25 (4): 358-61. 10.1093/pubmed/fdg088.PubMedCrossRef Sherriff LC, Mayon-White RT: A survey of hepatitis C prevalence amongst the homeless community in Oxford. Journal of Public Health Medicine. 2003, 25 (4): 358-61. 10.1093/pubmed/fdg088.PubMedCrossRef
80.
go back to reference Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ: HIV and Hepatitis C co-infection within CAESAR study. HIV Medicine. 2004, 5 (3): 174-9. 10.1111/j.1468-1293.2004.00207.x.PubMedCrossRef Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ: HIV and Hepatitis C co-infection within CAESAR study. HIV Medicine. 2004, 5 (3): 174-9. 10.1111/j.1468-1293.2004.00207.x.PubMedCrossRef
81.
go back to reference Robinson GM, Reynolds JN, Robinson BJ: hepatitis C prevalence and needle exchange/syringe sharing behaviours in recent onset injecting drug users. New Zealand Medical Journal. 1995, 108 (996): 103-5.PubMed Robinson GM, Reynolds JN, Robinson BJ: hepatitis C prevalence and needle exchange/syringe sharing behaviours in recent onset injecting drug users. New Zealand Medical Journal. 1995, 108 (996): 103-5.PubMed
82.
go back to reference Goldberg D, Mc Menamin J: The United Kingdom's hepatitis B immunistion strategy-where now?. Communicable Disease and Public Health. 1998, 1 (2): 79-83.PubMed Goldberg D, Mc Menamin J: The United Kingdom's hepatitis B immunistion strategy-where now?. Communicable Disease and Public Health. 1998, 1 (2): 79-83.PubMed
83.
go back to reference Edmunds WJ: Universal or selective immunisation against hepatitis B in United Kingdom? A review of recent cost-effectiveness studies. Communicable Disease and Public Health. 1998, 1 (4): 221-228.PubMed Edmunds WJ: Universal or selective immunisation against hepatitis B in United Kingdom? A review of recent cost-effectiveness studies. Communicable Disease and Public Health. 1998, 1 (4): 221-228.PubMed
84.
go back to reference Hallett RL, Ngui SL, Meigh RE, Mutton KJ, Boxall EH, Teo CG: Widespread dissemination in England of a stable and persistent hepatitis B virus variant. Clinical Infectious Diseases. 2004, 39 (7): 945-5. 10.1086/423962.PubMedCrossRef Hallett RL, Ngui SL, Meigh RE, Mutton KJ, Boxall EH, Teo CG: Widespread dissemination in England of a stable and persistent hepatitis B virus variant. Clinical Infectious Diseases. 2004, 39 (7): 945-5. 10.1086/423962.PubMedCrossRef
85.
go back to reference Hope VD, Ncube F, Hickman M, Judd A, Parry JV: Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: is the prison vaccination programme driving recent improvements. Journal of Viral Hepatitis. 2007, 14 (9): 653-60. 10.1111/j.1365-2893.2007.00856.x.PubMedCrossRef Hope VD, Ncube F, Hickman M, Judd A, Parry JV: Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: is the prison vaccination programme driving recent improvements. Journal of Viral Hepatitis. 2007, 14 (9): 653-60. 10.1111/j.1365-2893.2007.00856.x.PubMedCrossRef
86.
go back to reference Goudeau A: Epidemiology and eradication strategy for hepatitis B in Europe. The European Regional Study Group. 1990, 8 (Suppl): S113- Goudeau A: Epidemiology and eradication strategy for hepatitis B in Europe. The European Regional Study Group. 1990, 8 (Suppl): S113-
87.
go back to reference Raptopoulou M, Papatheodoridis G, Antoniou A, Ketikoglou J, Tzourmakliotis D, Vasiliadis T, Manolaki N, Nikolopoulou G, Manesis E, Pierroutsakos I: Epidemiology, course and disease burden of chronic hepatitis B virus infection. HEPNET study for chronic hepatitis B: a multicentre Greek study. Journal of Viral Hepatitis. 2009, 16 (3): 195-20. 10.1111/j.1365-2893.2008.01057.x.PubMedCrossRef Raptopoulou M, Papatheodoridis G, Antoniou A, Ketikoglou J, Tzourmakliotis D, Vasiliadis T, Manolaki N, Nikolopoulou G, Manesis E, Pierroutsakos I: Epidemiology, course and disease burden of chronic hepatitis B virus infection. HEPNET study for chronic hepatitis B: a multicentre Greek study. Journal of Viral Hepatitis. 2009, 16 (3): 195-20. 10.1111/j.1365-2893.2008.01057.x.PubMedCrossRef
88.
go back to reference Jutavijittum P, Yousukh A, Samountry B, Samountry K, Ounavong A, Thammavong T, Keokhamphue J, Toriyama K: Seroprevalence of hepatitis B and C virus infections among Lao blood donors. The Southeast Asian journal of tropical medicine and public health. 2007, 38 (4): 674-PubMed Jutavijittum P, Yousukh A, Samountry B, Samountry K, Ounavong A, Thammavong T, Keokhamphue J, Toriyama K: Seroprevalence of hepatitis B and C virus infections among Lao blood donors. The Southeast Asian journal of tropical medicine and public health. 2007, 38 (4): 674-PubMed
89.
go back to reference Acharya SK, Madan K, Dattagupta S, Panda SK: Viral Hepatitis in India. National Medical Journal of India Viral hepatitis in India. 2006, 19 (4): 203-17. Acharya SK, Madan K, Dattagupta S, Panda SK: Viral Hepatitis in India. National Medical Journal of India Viral hepatitis in India. 2006, 19 (4): 203-17.
90.
go back to reference Zuckerman J, Langer B: Hepatitis B vaccination in a school age population: a feasibility study. Journal of Medical Virology. 2005, 76 (1): 47-54. 10.1002/jmv.20335.PubMedCrossRef Zuckerman J, Langer B: Hepatitis B vaccination in a school age population: a feasibility study. Journal of Medical Virology. 2005, 76 (1): 47-54. 10.1002/jmv.20335.PubMedCrossRef
91.
go back to reference Mele A, Stroffolini T, Zanetti AR: Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination. Journal of Medical Virology. 2002, 67 (3): 440-3. 10.1002/jmv.10092.PubMedCrossRef Mele A, Stroffolini T, Zanetti AR: Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination. Journal of Medical Virology. 2002, 67 (3): 440-3. 10.1002/jmv.10092.PubMedCrossRef
92.
go back to reference Gonzales R, Glik D, Prelip M, Bourque L, Yuen J, Ang A, Jones M: Risk perceptions and behavioural intentions for Hepatitis B: how young people fare. Health Education Research. 2006, 21 (5): 654-656. 10.1093/her/cyl047.PubMedCrossRef Gonzales R, Glik D, Prelip M, Bourque L, Yuen J, Ang A, Jones M: Risk perceptions and behavioural intentions for Hepatitis B: how young people fare. Health Education Research. 2006, 21 (5): 654-656. 10.1093/her/cyl047.PubMedCrossRef
93.
go back to reference Haldar A, Sarkar A, Dasgupta U: Perception of general population about hepatitis B: a cross-sectional study. Journal of Communicable Diseases. 2005, 37 (2): 115-19.PubMed Haldar A, Sarkar A, Dasgupta U: Perception of general population about hepatitis B: a cross-sectional study. Journal of Communicable Diseases. 2005, 37 (2): 115-19.PubMed
94.
go back to reference Schenkel K, Radun D, Bremer V, Bocter N, Hamouda O: Viral hepatitis in Germany: poor vaccination coverage and little knowledge about transmission in target groups. BioMed Central Public Health. 2008, 8: 132-PubMedCentralPubMedCrossRef Schenkel K, Radun D, Bremer V, Bocter N, Hamouda O: Viral hepatitis in Germany: poor vaccination coverage and little knowledge about transmission in target groups. BioMed Central Public Health. 2008, 8: 132-PubMedCentralPubMedCrossRef
95.
go back to reference Best D, Noble A, Finch E, Gossop M, Sidwell C, Strang J: Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment. British Medical Journal. 1999, 319 (7205): 290-1.PubMedCentralPubMedCrossRef Best D, Noble A, Finch E, Gossop M, Sidwell C, Strang J: Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment. British Medical Journal. 1999, 319 (7205): 290-1.PubMedCentralPubMedCrossRef
96.
go back to reference Carter H, Robinson G, Hanlon C, Hailwood C, Massarotto A: Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination. New Zealand Medical Journal. 2001, 114 (1136): 324-PubMed Carter H, Robinson G, Hanlon C, Hailwood C, Massarotto A: Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination. New Zealand Medical Journal. 2001, 114 (1136): 324-PubMed
97.
go back to reference Zanis DA, Woody GE: One year mortality rates following methadone treatment discharge. Drug and Alcohol Dependence. 1998, 52 (3): 257-60. 10.1016/S0376-8716(98)00097-0.PubMedCrossRef Zanis DA, Woody GE: One year mortality rates following methadone treatment discharge. Drug and Alcohol Dependence. 1998, 52 (3): 257-60. 10.1016/S0376-8716(98)00097-0.PubMedCrossRef
98.
go back to reference Webb L, Oyefeso , Schifano F, Cheeta S, Pollard M, Ghodse AH: Cause and manner of death in drug related fatality: an analysis of drug related deaths recorded by coroners in England and Wales in 2000. Drug and Alcohol Dependence. 2003, 72 (1): 67-74. 10.1016/S0376-8716(03)00191-1.PubMedCrossRef Webb L, Oyefeso , Schifano F, Cheeta S, Pollard M, Ghodse AH: Cause and manner of death in drug related fatality: an analysis of drug related deaths recorded by coroners in England and Wales in 2000. Drug and Alcohol Dependence. 2003, 72 (1): 67-74. 10.1016/S0376-8716(03)00191-1.PubMedCrossRef
99.
go back to reference Preti A, Miotto P, De Coppi M: Deaths by unintentional illicit drug overdose in Italy 1984-2000. Drug and Alcohol Dependence. 2002, 66: 275-282. 10.1016/S0376-8716(01)00207-1.PubMedCrossRef Preti A, Miotto P, De Coppi M: Deaths by unintentional illicit drug overdose in Italy 1984-2000. Drug and Alcohol Dependence. 2002, 66: 275-282. 10.1016/S0376-8716(01)00207-1.PubMedCrossRef
100.
go back to reference Hickman M, Carnwath Z, Madden P, Farrell , Rooney C, Ashcroft R, Judd A, Stimson C: Drug related mortality and fatal overdose risk; pilot cohort study of heroin users recruited from specialist drug treatment sites in London. Journal of Urban Health. 2003, 80 (2): 274-87.PubMedCentralPubMedCrossRef Hickman M, Carnwath Z, Madden P, Farrell , Rooney C, Ashcroft R, Judd A, Stimson C: Drug related mortality and fatal overdose risk; pilot cohort study of heroin users recruited from specialist drug treatment sites in London. Journal of Urban Health. 2003, 80 (2): 274-87.PubMedCentralPubMedCrossRef
101.
go back to reference Hickman M, Madden P, Henry J, Baker A, Wallace C, Wakefield J, Stimson C, Elliott P: Trends in drug overdose deaths in England and Wales 1993-98: methadone does not kill more people than heroin. Addiction. 2003, 98 (4): 419-25. 10.1046/j.1360-0443.2003.00294.x.PubMedCrossRef Hickman M, Madden P, Henry J, Baker A, Wallace C, Wakefield J, Stimson C, Elliott P: Trends in drug overdose deaths in England and Wales 1993-98: methadone does not kill more people than heroin. Addiction. 2003, 98 (4): 419-25. 10.1046/j.1360-0443.2003.00294.x.PubMedCrossRef
102.
go back to reference Quaglio G, Talamini G, Lechi A, Venturini L, Lugoboni F, Mezzelani P, Gruppo Intersert di Collaborazione Scientifica: Study of 2708 heroin related deaths in north eastern Italy 1985-98 to establish the main cause of death. Addiction. 2001, 96 (8): 1127-37. 10.1046/j.1360-0443.2001.96811276.x.PubMedCrossRef Quaglio G, Talamini G, Lechi A, Venturini L, Lugoboni F, Mezzelani P, Gruppo Intersert di Collaborazione Scientifica: Study of 2708 heroin related deaths in north eastern Italy 1985-98 to establish the main cause of death. Addiction. 2001, 96 (8): 1127-37. 10.1046/j.1360-0443.2001.96811276.x.PubMedCrossRef
103.
go back to reference Gronblahd L, Ohlund LS, Gunne LM: Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatrica Scandinavica. 1990, 82 (3): 223-7. 10.1111/j.1600-0447.1990.tb03057.x.CrossRef Gronblahd L, Ohlund LS, Gunne LM: Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatrica Scandinavica. 1990, 82 (3): 223-7. 10.1111/j.1600-0447.1990.tb03057.x.CrossRef
104.
go back to reference Davoli M, Perucci CA, Forastiere F, Doyal P, Rapiti E, Zaccarelli M: Risk factors for overdose mortality: a case control study within a cohort of intravenous drug users. International Journal of Epidemiology. 1993, 22 (2): 273-277. 10.1093/ije/22.2.273.PubMedCrossRef Davoli M, Perucci CA, Forastiere F, Doyal P, Rapiti E, Zaccarelli M: Risk factors for overdose mortality: a case control study within a cohort of intravenous drug users. International Journal of Epidemiology. 1993, 22 (2): 273-277. 10.1093/ije/22.2.273.PubMedCrossRef
105.
go back to reference Caplehorn JR, Dalton MS, Haldar F, Petrenas AM, Nisbet JG: Methadone Maintenance and addicts' risk of fatal heroin overdose. Substance Use & Misuse. 1996, 31 (2): 177-96. 10.3109/10826089609045806.CrossRef Caplehorn JR, Dalton MS, Haldar F, Petrenas AM, Nisbet JG: Methadone Maintenance and addicts' risk of fatal heroin overdose. Substance Use & Misuse. 1996, 31 (2): 177-96. 10.3109/10826089609045806.CrossRef
106.
go back to reference Brugal MT, Domingo-Salvany A, Puig R, Barrio G, Garcia De Olalla P, de la Fuente L: Evaluating the impact of methadone maintenance programmes on mortality due to overdose and AIDS in a cohort of heroin users in Spain. Addiction. 2005, 100 (7): 981-9. 10.1111/j.1360-0443.2005.01089.x.PubMedCrossRef Brugal MT, Domingo-Salvany A, Puig R, Barrio G, Garcia De Olalla P, de la Fuente L: Evaluating the impact of methadone maintenance programmes on mortality due to overdose and AIDS in a cohort of heroin users in Spain. Addiction. 2005, 100 (7): 981-9. 10.1111/j.1360-0443.2005.01089.x.PubMedCrossRef
107.
go back to reference Darke S, Williamson A, Ross J, Teesson M: Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS). Drug & Alcohol Review. 2005, 24 (5): 425-32. 10.1080/09595230500286005.CrossRef Darke S, Williamson A, Ross J, Teesson M: Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS). Drug & Alcohol Review. 2005, 24 (5): 425-32. 10.1080/09595230500286005.CrossRef
Metadata
Title
Problem drug use the public health imperative: what some of the literature says
Author
Gez Bevan
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Substance Abuse Treatment, Prevention, and Policy / Issue 1/2009
Electronic ISSN: 1747-597X
DOI
https://doi.org/10.1186/1747-597X-4-21

Other articles of this Issue 1/2009

Substance Abuse Treatment, Prevention, and Policy 1/2009 Go to the issue